17 June 2021

GSK Stockmann contributed to the publication of the Chinese Outbound Investment Guide 2021

The Chinese Outbound Investment Guide 2021 has been published by the International Financial Law Review (IFLR); IFLR has partnered with leading advisors to share their knowledge and vision for Chinese outbound investment.

GSK Stockmann contributed to the guide: Dr. Marcus Peter (Partner at GSK Stockmann in Luxembourg) and Kate Yu Rao (Senior Associate at GSK Stockmann in Luxembourg) composed the chapter “Optimistic outlook for Chinese investment into Luxembourg in post-Covid times” outlining why the outlook for Chinese investment into Luxembourg remains positive, despite the temporary change in investment conditions due to Covid-19.

The chapter is available for download as a PDF file and free to access on the IFLR Website.

Print


Press contact
Beate Dünschede
+352 271802-29
beate.duenschede@gsk-lux.com

Back

GSK Updates
  • 07.05.2021

    GSK Update: Introducing the new sustainable finance measures of the EU Commission

    Read more
  • 30.03.2021

    GSK Update: SFDR – new RTS – What you should know

    Read more
  • 10.02.2021

    GSK Update: Blockchain II Law: Another step forward for the digitalization of EU capital markets

    Read more
Contact person

Dr. Marcus Peter, LL.M.

Partner

+352 271802-50

marcus.peter@gsk-lux.com

Kate Rao, LL.M.

Senior Associate

+352 271802-54

kate.rao@gsk-lux.com

© GSK Stockmann 2021